Baxter’s employees worldwide are essential to creating products that save and sustain lives. The company is continually improving its programs to provide a safe, healthy and inclusive workplace and to foster a culture that drives integrity and innovation.
Implement best-in-class programs designed to protect the safety and improve the health of employees that result in performance in the top three of industry peers.
Compared to 2012, Baxter improved its recordable case rate by 2%, its cases with days lost rate by 38%, and its days lost rate by 46%. In a comparison of 141 healthcare companies, Baxter’s performance ranked second best in cases with days lost rate in 2012, the most recent year industry benchmarking data were available. Learn More
Create and sustain an inclusive culture where diverse ideas, backgrounds, experiences and perspectives are respected and valued.
The company continues to focus on capability building with managers and leaders through a mandatory in-person Power of Managing Inclusively workshop. In 2013, Baxter also established three additional Business Resource Groups (BRGs), Baxter EnAbles (for employees living with or supporting those with physical, sensory or cognitive disabilities), BaxVets (for employees who have served or serve in the military) and Early Career Professionals (for employees at earlier stages in their careers), for a total of eight BRGs. The company also began global expansion of several of the BRGs. Learn More
Continue to champion internal and industrywide ethical sales and marketing practices by:
Baxter is enhancing its policies that govern how the company, its employees and third parties interact with the medical community. This includes investment in new systems and programs that support better management, transparency and control of these interactions. For example, in 2013, Baxter’s Contributions Management Program removed customer-facing teams from reviewing and processing requests from not-for profit and for-profit healthcare organizations. Learn More
Baxter has been working with the European Federation of Pharmaceutical Industries and Associations to share the company’s perspective on interactions with the medical community and disclosing such interactions. Baxter also continued to share the company’s perspectives with Eucomed on the development of a general ethics and compliance program. Additionally, Baxter China’s Ethics and Compliance (E&C) team continued to work with the China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee (RDPAC) on an industry-wide ethical sales and marketing code. In Latin America, Baxter continues to work with the Mexican Association of Innovative Medical Devices Industries (AMID) in a variety of ways, including updating AMID’s Code of Interactions with Healthcare Professionals to ensure the highest international and local ethics standards. Learn More